Terry Murdock
Chief Operating Officer chez G1 THERAPEUTICS, INC.
Fortune : 447 716 $ au 31/03/2024
Profil
Terry L.
Murdock is currently the Chief Operating Officer at G1 Therapeutics, Inc. He previously worked as the Executive Director-Global Clinical Operations at Ergomed Plc.
From 2001 to 2012, he held the position of Senior Vice President-Clinical Operations at ILEX Oncology, Inc. He also served as the VP & Global Head-Oncology Center for Excellence at IQVIA Holdings, Inc. from 2014 to 2017.
Prior to that, he was the Vice President-Research at The US Oncology Network from 1995 to 2001.
Mr. Murdock completed his undergraduate and graduate degrees at The University of Texas at Austin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
G1 THERAPEUTICS, INC.
0,20% | 04/01/2024 | 103 638 ( 0,20% ) | 447 716 $ | 31/03/2024 |
Postes actifs de Terry Murdock
| Sociétés | Poste | Début |
|---|---|---|
| G1 THERAPEUTICS, INC. | Chief Operating Officer | 01/01/2019 |
Anciens postes connus de Terry Murdock
| Sociétés | Poste | Fin |
|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | 01/07/2017 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Chief Operating Officer | 01/05/2012 |
| The US Oncology Network | Corporate Officer/Principal | 01/01/2001 |
| ERGOMED | Chief Tech/Sci/R&D Officer | - |
Formation de Terry Murdock
| The University of Texas at Austin | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| ERGOMED | Commercial Services |
| IQVIA HOLDINGS INC. | Health Services |
| Entreprise privées | 2 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
| The US Oncology Network |
